InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Kraus Carl N, Chief Medical Officer. Officer active across 1 companies, notably Aquestive Therapeutics, Inc.. In total, 2 filings have been published. Total volume traded: €244k. The latest transaction was disclosed on 15 October 2025 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
US$121,84420,272 shares@ US$6.01050.015% mcap100.0% of flow
Common Stock
SEC:0001214659-25-015047·
€121,84420,272 shares@ €6.01050.015% mcap50.0% of flow
Common Stock
SEC:0001214659-25-015047:0·
2 of 2 declarations
About Kraus Carl N
Kraus Carl N is the Chief Medical Officer of Aquestive Therapeutics, Inc. He is responsible for the medical strategy and clinical development of the company, which focuses on innovative treatments. His role is essential in ensuring that Aquestive's products meet safety and efficacy standards.
